MICHAEL HUNTER: Open Payments
NPI 1528447521 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,804 in 40 payments from 14 companies in 2025. Trend: 2023 $2,202 · 2024 $2,088 · 2025 $1,804
Food & beverage: $1,804
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $456 |
| Nalu Medical, Inc. | 6 | $394 |
| Boston Scientific Corporation | 9 | $331 |
| Globus Medical, Inc. | 7 | $256 |
| SI-BONE, INC. | 2 | $85 |
| Medtronic, Inc. | 2 | $68 |
| Averitas Pharma Inc. | 2 | $43 |
| Valinor Pharma, LLC | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Stryker Corporation | 1 | $28 |
Products named: Nalu Neurostimulation System, Intracept, PROCLAIM, ETERNA, Vyrsa V1, Senza, WaveWriter Alpha Prime 16, QUTENZA.
Industry payments across TX — which companies pay providers there.
